Profile data is unavailable for this security.
About the company
Double Bond Pharmaceutical International AB is a manufacturer of pharmaceutical preparation. The company is located in Uppsala, Sweden. It develops medicinal products for patients suffering from diseases such as cancer, inflammation, asthma or diabetes
- Revenue in SEK (TTM)1.49m
- Net income in SEK-16.07m
- Incorporated2014
- Employees10.00
- LocationDouble Bond Pharmaceutical International AB (publ)Virdings Alle 32 BUPPSALA 75450SwedenSWE
- Websitehttps://www.doublebp.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gabather AB | 0.00 | -9.44m | 31.26m | -- | -- | 50.03 | -- | -- | -0.652 | -0.652 | 0.00 | 0.0331 | 0.00 | -- | -- | -- | -133.71 | -56.57 | -480.99 | -67.36 | -- | -- | -- | -17,298,800.00 | -- | -- | -- | -- | -- | -- | -10.40 | -- | -- | -- |
| Fluicell AB | 1.86m | -29.02m | 33.17m | 12.00 | -- | 1.92 | -- | 17.80 | -0.1936 | -0.1936 | 0.0109 | 0.0527 | 0.0796 | 0.5404 | 1.74 | 109,588.20 | -123.93 | -87.55 | -164.04 | -126.02 | 20.93 | 72.97 | -1,557.49 | -650.23 | 3.02 | -- | 0.00 | -- | 2.68 | 22.18 | -22.90 | -- | -- | -- |
| Elicera Therapeutics AB | 12.85m | -19.50m | 34.11m | 2.00 | -- | 1.08 | -- | 2.65 | -0.9726 | -0.9726 | 0.6416 | 0.901 | 0.3015 | -- | 11.43 | 6,426,955.00 | -45.75 | -40.06 | -62.75 | -49.74 | -- | -- | -151.72 | -415.41 | -- | -- | 0.00 | -- | 777.23 | -- | 15.64 | -- | -- | -- |
| Lipigon Pharmaceuticals AB | 16.41m | -12.13m | 36.85m | -- | -- | 1.30 | -- | 2.25 | -0.4662 | -0.4662 | 0.3201 | 0.225 | 0.7388 | -- | 14.81 | -- | -54.60 | -314.67 | -75.05 | -426.49 | -- | -- | -73.91 | -488.14 | -- | -- | 0.00 | -- | -- | 444.44 | 67.83 | -- | -- | -- |
| Modus Therapeutics Holding AB | 0.00 | -14.96m | 38.63m | 2.00 | -- | 2.65 | -- | -- | -0.7495 | -0.7495 | 0.00 | 0.4056 | 0.00 | -- | -- | 0.00 | -128.10 | -141.06 | -502.76 | -278.44 | -- | -- | -- | -- | -- | -11.79 | 0.00 | -- | -- | -- | 2.31 | -- | -- | -- |
| Oncozenge AB | 0.00 | -14.22m | 40.53m | -- | -- | 2.49 | -- | -- | -1.21 | -1.21 | 0.00 | 1.39 | 0.00 | -- | -- | -- | -58.23 | -- | -61.58 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 65.91 | -- | -- | -- |
| SoftOx Solutions AS | 7.00m | -42.21m | 45.92m | -- | -- | -- | -- | 6.56 | -1.98 | -1.98 | 0.3286 | -0.0127 | 0.081 | -- | 1.60 | -- | -48.81 | -50.83 | -82.20 | -64.58 | -- | -- | -602.91 | -646.67 | 0.1745 | -3.45 | -- | -- | -1.88 | 10.06 | 40.85 | -- | 39.43 | -- |
| Veg of Lund AB (publ) | 3.10m | -14.81m | 48.90m | 5.00 | -- | 1.29 | -- | 15.75 | -0.5218 | -0.5218 | 0.0893 | 0.9198 | 0.0987 | 9.87 | 4.05 | 443,428.60 | -47.08 | -129.03 | -83.38 | -209.20 | -449.52 | -781.09 | -477.09 | -923.73 | 0.0949 | -11.52 | 0.2468 | -- | 89.57 | 39.87 | 56.02 | -- | -12.47 | -- |
| Double Bond Phrmcutcl Intrntnl AB (publ) | 1.49m | -16.07m | 50.51m | 10.00 | -- | 7.84 | -- | 33.88 | -0.1635 | -0.1635 | 0.0145 | 0.0638 | 0.1306 | -- | 26.83 | 149,078.00 | -140.73 | -80.90 | -200.07 | -106.45 | -389.14 | -1,073.66 | -1,078.00 | -1,360.03 | -- | -2.71 | 0.00 | -- | 10.25 | 135.07 | -14.36 | -- | -- | -- |
| Orphazyme A/S | 0.00 | -39.89m | 54.60m | 1.00 | -- | 2.50 | -- | -- | -737.75 | -737.75 | 0.00 | 403.34 | 0.00 | -- | -- | 0.00 | -68.42 | -76.08 | -94.18 | -105.34 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 32.00 | -- | -- | -- |
| Immunovia AB (publ) | 1.21m | -260.73m | 64.76m | 11.00 | -- | 1.48 | -- | 53.43 | -6.06 | -6.06 | 0.0276 | 0.9648 | 0.0075 | 58.23 | 14.96 | 110,181.80 | -160.93 | -41.33 | -194.89 | -44.24 | -5,523.76 | -7,553.76 | -21,512.13 | -20,879.29 | 2.03 | -- | 0.1675 | -- | 37.55 | 36.48 | -84.09 | -- | -50.93 | -- |
| ExpreS2ion Biotech Holding AB | 7.77m | -77.95m | 65.80m | 18.00 | -- | 1.26 | -- | 8.47 | -1.56 | -1.56 | 0.1509 | 1.02 | 0.0821 | -- | 4.87 | 298,730.80 | -82.36 | -63.54 | -113.92 | -75.88 | -132.91 | -1.94 | -1,003.55 | -524.31 | -- | -- | 0.0055 | -- | 43.07 | -0.1561 | 22.94 | -- | 19.90 | -- |
| Spago Nanomedical AB (publ) | 1.47m | -35.58m | 65.84m | 12.00 | -- | 1.92 | -- | 44.91 | -0.3129 | -0.3129 | 0.0113 | 0.1525 | 0.0324 | -- | 9.91 | 112,769.20 | -78.60 | -20.19 | -93.27 | -20.97 | -5.25 | -- | -2,426.88 | -4,853.45 | -- | -- | 0.00 | -- | 14.14 | -- | -7.72 | -- | -- | -- |
| Klaria Pharma Holding AB (publ) | -6.53m | -20.10m | 67.73m | 5.00 | -- | 1.90 | -- | -- | -0.1847 | -0.4021 | -0.0621 | 0.2743 | -0.0794 | -- | -- | -1,305,600.00 | -24.44 | -37.28 | -40.23 | -51.56 | -- | -- | -- | -2,077.34 | -- | -1.87 | 0.00 | -- | -100.00 | -- | 71.17 | -- | -- | -- |
| Combigene AB | 3.70m | -35.24m | 69.11m | 8.00 | -- | 0.6758 | -- | 18.67 | -1.78 | -1.78 | 0.187 | 5.16 | 0.0294 | -- | 1.27 | 462,765.00 | -27.99 | -13.00 | -29.40 | -14.58 | -- | -- | -951.98 | -58.77 | -- | -- | 0.00 | -- | -79.23 | 268.58 | -479.27 | -- | -24.02 | -- |
| Abera Bioscience AB | 0.00 | -12.70m | 70.16m | 6.00 | -- | 7.13 | -- | -- | -0.9261 | -0.9261 | 0.00 | 0.6407 | 0.00 | -- | -- | 0.00 | -90.08 | -79.42 | -117.23 | -96.10 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 13.74 | -- | -- | -- |
Data as of May 31 2024. Currency figures normalised to Double Bond Pharmaceutical International AB (publ)'s reporting currency: Swedish Krona SEK
